Acorda Therapeutics Inc (ACORQ)
0.85
+0.15
(+21.43%)
USD |
OTCM |
May 21, 16:00
Acorda Therapeutics 1 Year Total Returns (Daily): -94.48% for May 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 21, 2024 | -94.48% |
May 20, 2024 | -95.45% |
May 17, 2024 | -96.27% |
May 16, 2024 | -96.81% |
May 15, 2024 | -94.91% |
May 14, 2024 | -97.27% |
May 13, 2024 | -97.41% |
May 10, 2024 | -97.42% |
May 09, 2024 | -96.31% |
May 08, 2024 | -95.57% |
May 07, 2024 | -91.12% |
May 06, 2024 | -91.92% |
May 03, 2024 | -91.33% |
May 02, 2024 | -90.96% |
May 01, 2024 | -91.06% |
April 30, 2024 | -92.47% |
April 29, 2024 | -90.32% |
April 26, 2024 | -91.90% |
April 25, 2024 | -91.67% |
April 24, 2024 | -94.15% |
April 23, 2024 | -94.69% |
April 22, 2024 | -95.31% |
April 19, 2024 | -95.93% |
April 18, 2024 | -96.38% |
April 17, 2024 | -96.71% |
Date | Value |
---|---|
April 16, 2024 | -96.42% |
April 15, 2024 | -96.23% |
April 12, 2024 | -95.86% |
April 11, 2024 | -93.99% |
April 10, 2024 | -91.93% |
April 09, 2024 | -90.56% |
April 08, 2024 | -88.89% |
April 05, 2024 | -86.91% |
April 04, 2024 | -84.88% |
April 03, 2024 | -82.38% |
April 02, 2024 | -78.67% |
April 01, 2024 | 14.93% |
March 28, 2024 | 12.97% |
March 27, 2024 | 4.11% |
March 26, 2024 | 10.36% |
March 25, 2024 | 12.19% |
March 22, 2024 | 1.68% |
March 21, 2024 | -1.54% |
March 20, 2024 | 1.69% |
March 19, 2024 | 2.73% |
March 18, 2024 | 4.67% |
March 15, 2024 | -0.80% |
March 14, 2024 | 4.40% |
March 13, 2024 | -8.47% |
March 12, 2024 | -6.91% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.42%
Minimum
May 10 2024
178.9%
Maximum
Sep 25 2023
-47.16%
Average
-66.17%
Median
Apr 12 2023
1 Year Total Returns (Daily) Benchmarks
BioSig Technologies Inc | -87.22% |
Verve Therapeutics Inc | -66.91% |
Spectral AI Inc | -83.08% |
AIM ImmunoTech Inc | -13.52% |
Protalix BioTherapeutics Inc | -41.18% |